Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
2019 · Cancer Cell · 1,057 citations
https://doi.org/10.1016/j.ccell.2019.02.001
Y
Yi Xiao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
120
Papers
3.9K
Citations
29
h-index
36
i10-index
Yi Xiao is an academic researcher from Children's Medical Center. The author has contributed to research in topics: Renal cell carcinoma treatment & Ferroptosis and cancer prognosis & Cancer, Hypoxia, and Metabolism. The author has an h-index of 29, co-authored 102 publications.
ORCID: 0000-0002-3817-3471Papers by this author
worksFerroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
2022 · Cell Metabolism · 527 citations
https://doi.org/10.1016/j.cmet.2022.09.021
Advances in targeting histone deacetylase for treatment of solid tumors
2024 · Journal of Hematology & Oncology · 106 citations
https://doi.org/10.1186/s13045-024-01551-8
Establishment of patient-derived organoid models of lower-grade glioma
2021 · Neuro-Oncology · 89 citations
https://doi.org/10.1093/neuonc/noab273
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
2024 · Nature Cancer · 77 citations
https://doi.org/10.1038/s43018-024-00725-0
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
2024 · Science · 72 citations
https://doi.org/10.1126/science.adl6173
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat